Evidence map›Paper›PMID 41641634›Full record

ArticleHaematologica2026

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Margaux Poussard, Morgane Boichut, Imane Belakri, Sabeha Biichle, Maxime Fredon, Blandine Cael, Xavier Roussel, Florian Renosi, Kris Van Moer, Bassam Janji and 9 more

Abstract read
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Margaux PoussardUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France; Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, L-1210, Luxembourg.
Morgane BoichutUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon.
Imane BelakriUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon.
Sabeha BiichleUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon.
Maxime FredonCARLA Biotherapeutics, F-25000 Besançon.
Blandine CaelUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon.
Xavier RousselUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France; Service d'hematologie clinique, CHU Besançon, F-25000 Besançon.
Florian RenosiUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France; Laboratoire d'onco-hematologie moléculaire, CHU Besancon, F-25000 Besançon.
Kris Van MoerDepartment of Cancer Research, Luxembourg Institute of Health, Luxembourg, L-1210, Luxembourg.
Bassam JanjiDepartment of Cancer Research, Luxembourg Institute of Health, Luxembourg, L-1210, Luxembourg.
Franck MonnienDepartment of Pathology, CHU Besançon, Besançon.
Cecile BoichutDepartment of Pathology, CHU Besançon, Besançon.
Romain BoidotUnit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, F-21000 Dijon.
Babacar NdaoUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon.
Olivier AdoteviUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France; Service d'oncologie médicale, CHU Besancon, F-25000 Besançon.
Francine Garnache-OttouUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France; Laboratoire d'immunologie cellulaire et hématologie, CHU Besancon, F-25000 Besançon.
Kristal WatkinsImmunoGen, Inc., Waltham, United States of America.
Sribalaji LakshmikanthanImmunoGen, Inc., Waltham, United States of America.
Fanny Angelot-DelettreUniversité Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, F-25000 Besançon. fanny.delettre@efs.sante.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41641634
PMCPMC13628004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.